A vs CORT · P/E 29, rev $1.88B vs P/E 199, rev $675.0M
Agilent Technologies Inc (A) versus Corcept Therapeutics Incorporated (CORT) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
A currently screens at market cap $33.70B and trailing P/E 29.2. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Not investment advice. Open the A and CORT stock pages for the full models.
Not investment advice.